SPAC · Merger completed
Locust Walk Acquisition Corp.
Business combination with eFFECTOR Therapeutics, Inc.
Locust Walk Acquisition Corp. is a blank-check company (SPAC) that raised $153M in its initial public offering on Jan 11, 2021, listing on Nasdaq. It completed its business combination with eFFECTOR Therapeutics, Inc. on Aug 25, 2021; the combined company is eFFECTOR Therapeutics, Inc. (EFTR). Cantor led the IPO. Ellenoff Grossman & Schole advised the underwriters on the IPO.
- Status
- Merger completed
- IPO date
- Jan 11, 2021
- IPO size
- $153M
- IPO exchange
- Nasdaq
- Target
- eFFECTOR Therapeutics, Inc.
- Announced
- May 27, 2021
- Closed
- Aug 25, 2021
- Combined company
- eFFECTOR Therapeutics, Inc. (EFTR)
- IPO underwriters
- Cantor
- Underwriters' counsel (IPO)
- Ellenoff Grossman & Schole
More on this SPAC for subscribers
- Trust balance and value per share
- Redemptions at each extension and at the merger vote
- Liquidation deadline and extension history
- PIPE and other committed financing
- Merger proxy, registration statement and investor presentation
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Jan 11, 2021
- Deal announcement (8-K) May 27, 2021
- All filings on EDGAR CIK 1828522
Other deSPACs that closed in 2021
- IronNet, Inc.via LGL Systems Acquisition Corp. · closed Aug 26, 2021
- Nexters Inc.via Kismet Acquisition One Corp · closed Aug 26, 2021
- Humacyte, Inc.via Alpha Healthcare Acquisition Corp. · closed Aug 26, 2021
- Volta Inc.via Tortoise Acquisition Corp. II · closed Aug 26, 2021
- Rocket Lab USA, Inc.via Vector Acquisition Corporation · closed Aug 25, 2021
- SmartRent, Inc.via Fifth Wall Acquisition Corp. I · closed Aug 24, 2021